Overview
- On Oct. 30, Core Scientific said the sale was terminated after stockholders voted down CoreWeave’s proposal.
- The offer carried a fixed exchange ratio of 0.1235 CoreWeave shares per Core Scientific share with no collar, tying payouts to CoreWeave’s share price.
- Large holders Two Seas Capital and Gullane Capital opposed the deal, as did proxy advisors ISS and Glass Lewis, shaping the vote outcome.
- Core Scientific’s board had endorsed the merger for expected savings and synergies, while CoreWeave said it respects the decision and plans to continue their commercial partnership.
- Following the vote, Core Scientific shares fell about 3.4% and CoreWeave nearly 5%, marking CoreWeave’s second failed bid after a rejected all-cash offer in June 2024.